Internal Medicine · Tampa, FL
NPI
1568781953
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
4729 N Habana Ave
Tampa, FL, 33614
Phone (813) 251-8444
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
30,607 services
Medicare patients, 2024
483
Average age 69
Drug cost, 2024
$971K
809 prescriptions
Company payments, 2025
$283
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeniffer Torres-Velazco was code 99232 (hospital e&m - subsequent), 1,048 times for 336 patients. In total Jeniffer Torres-Velazco billed 30,607 services in 34 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,048 | 336 | $59.00 | $62K |
| 99222 Hospital E&M - Initial | Facility | 199 | 187 | $100.99 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 175 | 92 | $89.24 | $16K |
| 96365 Intravenous Infusion, Hydration | Office | 110 | 14 | $46.57 | $5,122 |
| 99231 Hospital E&M - Subsequent | Facility | 101 | 74 | $37.07 | $3,744 |
| 99214 Office E&M - Established | Office | 64 | 38 | $88.92 | $5,691 |
| 99223 Hospital E&M - Initial | Facility | 52 | 50 | $132.13 | $6,871 |
| 36415 Venipuncture Blood Collection | Office | 29 | 16 | $8.65 | $251 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 22 | 22 | $70.05 | $1,541 |
By year: 2022 $133K for 57,630 services; 2023 $130K for 5,471 services; 2024 $133K for 30,607 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 29 | 16 | $8.65 | $251 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeniffer Torres-Velazco prescribed most often to Medicare patients was Tivicay (Dolutegravir Sodium), with 49 prescriptions and refills. In total Jeniffer Torres-Velazco wrote 809 Medicare prescriptions that cost $971K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tivicay Dolutegravir Sodium | 49 | 49 | Under 11 | $106K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 47 | 47 | Under 11 | $191K |
| Ciprofloxacin Hcl Generic | 38 | 38 | 24 | $376 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 36 | 36 | Under 11 | $742 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 33 | 34 | Under 11 | $151K |
| Vancomycin Hcl Generic | 28 | 28 | 11 | $3,534 |
| Dovato Dolutegravir Sodium/Lamivudine | 26 | 26 | Under 11 | $73K |
| Isentress Raltegravir Potassium | 25 | 25 | Under 11 | $48K |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 25 | 33 | Under 11 | $9,057 |
| Daptomycin Generic | 22 | 22 | Under 11 | $23K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 20 | 20 | Under 11 | $69K |
| Valacyclovir Valacyclovir Hcl | 19 | 21 | Under 11 | $664 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 19 | 31 | Under 11 | $1,156 |
| Fluconazole Generic | 18 | 18 | Under 11 | $551 |
| Sodium Chloride 0.9 % Sodium Chloride | 18 | 18 | Under 11 | $193 |
Brand drugs: 312 claims; generic drugs: 497 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeniffer Torres-Velazco $283 ($283 in general payments such as food, travel and fees) from 6 companies. The largest payer was Astellas Pharma US Inc with $131.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.